Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic DiversitySimon D Pollett, Stephanie A Richard, Anthony C Fries, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 8, 2020
Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant HemagglutininWei Wang, Esmeralda Alvarado-Facundo, Russell Vassell, et al.
The Journal of Infectious Diseases|July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System BeneficiariesNusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Frontiers in Public Health|May 4, 2026
Influenza-like illness in cigarette smokers and electronic-cigarette users: a secondary analysis from the PAIVED studyRachael D C Jones, Kat Schmidt, Christina Schofield, et al.
Open Forum Infectious Diseases|January 14, 2026
Healthcare Workers Have More Frequent and Less Severe Influenza-Like Illness Than Non-healthcare Workers: Findings From the PAIVED StudyRyan Liberg, Kat Schmidt, Christina Schofield, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Virus Evolution|October 10, 2024
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversificationBethany L Dearlove, Anthony C Fries, Nusrat J Epsi, et al.
Open Forum Infectious Diseases|November 4, 2024
Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism RiskAndrew O'Carroll, Stephanie A Richard, Celia Byrne, et al.
Pageof 12